68
Asymchem Laboratories (Tianjin) Co., Ltd.
6821.HK · HKSE
$139.90 +6.23% (+$8.20)
1M +7.64%
Market Cap ¥40.7B
P/E Ratio 39.31x
Div. Yield 1.14%
ROE 5.86%
Bulios Fair Price
$129.99
7.1% downside
Current Price
$139.9
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6821.HK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
25 /100
Expensive P/E 39.31x
EV/EBITDA 24.86x
PEG 1.86x
Growth
5 /100
Declining EPS growth 29.23%
Rev. growth 13.36%
Book val. growth 4.07%
Profitability
55 /100
Moderate Gross margin 40.51%
Net margin 14.67%
FCF margin 0.90%
Quality
31 /100
Poor ROIC 5.78%
ROE 5.86%
Asset turnover 0.34x
Debt
100 /100
Low Debt/Equity 0.03x
Current ratio 4.56x
Net debt/EBITDA -3.49x
Stability
45 /100
Moderate Beta 0.06x
Rev. volatility 22.93%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6821.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hao Hong
Employees
10,617
Headquarters
Tianjin
Upcoming events
04 NOV
Earnings
Upcoming earnings report